Chimeric Antigen Receptor T-Cell Therapy of Neurolymphomatosis Monitored by FDG PET/CT. Li S, Wang H, Wang G, Lu X, et al. Clin Nucl Med 2023 Jan 30. doi: 10.1097/RLU.0000000000004584.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Li S, Wang H, Wang G, Lu X, et al. Chimeric Antigen Receptor T-Cell Therapy of Neurolymphomatosis Monitored by FDG PET/CT. Clin Nucl Med 2023 Jan 30. doi: 10.1097/RLU.0000000000004584.
PMID: 36716490